ACHIEVE LIFE SCIENCES, INC. 8-K

What Happened

• Achieve Life Sciences, Inc. announced that it filed a Certificate of Amendment to its Third Amended and Restated Certificate of Incorporation with the Delaware Secretary of State on July 6, 2026.
• The amendment was approved by the company’s board earlier in 2026 and by shareholders at the Annual Meeting held on July 2, 2026, as described in Proposal 4 of the proxy materials.
• A copy of the Certificate of Amendment is attached to the 8-K as Exhibit 3.1 and is incorporated by reference.

Key Details

• Certificate of Amendment filed: July 6, 2026 (Delaware Secretary of State).
• Stockholder approval: Annual Meeting on July 2, 2026 (approval of Proposal 4).
• Board approval: Previously approved by the company’s board of directors (earlier in 2026).
• Exhibit included: Exhibit 3.1 contains the full text of the Certificate of Amendment.

Why It Matters

• The filing legally changes the company’s certificate of incorporation; the specific effects depend on the amendment’s text (see Exhibit 3.1 for details).
• Investors should review the attached Certificate of Amendment to understand any changes to governance, capital structure, or shareholder rights resulting from Proposal 4.
• This 8-K does not include financial results or operational updates — it reports a corporate governance action that could affect shareholder interests depending on the amendment’s provisions.